Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 56, Issue 6

Issues

Gamma heavy chain disease evolving during the progression of chronic lymphocytic leukemia

Christoph Robier
  • Corresponding author
  • Institute of Laboratory Diagnostics, Hospital of the Brothers of St. John of God, Graz, Austria
  • Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Manfred Neubauer
  • Institute of Laboratory Diagnostics, Hospital of the Brothers of St. John of God, Graz, Austria
  • Hematologic Outpatient Clinic, Department of Internal Medicine, Hospital of the Brothers of St. John of God, Graz, Austria
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-01-09 | DOI: https://doi.org/10.1515/cclm-2017-0891

References

  • 1.

    Wahner-Roedler DL, Witzig TE, Loehrer LL, Kyle RA. γ-heavy chain disease: review of 23 cases. Medicine (Baltimore) 2003;82:236–50.CrossrefPubMedGoogle Scholar

  • 2.

    Wahner-Roedler DL, Kyle RA. Heavy chain diseases. Best Pract Res Clin Haematol 2005;18:729–46.CrossrefPubMedGoogle Scholar

  • 3.

    Presti BC, Sciotto CG, Marsh SG. Lymphocytic lymphoma with associated gamma heavy chain and IgM-lambda paraproteins. Am J Clin Pathol 1990;93:137–41.PubMedCrossrefGoogle Scholar

  • 4.

    Fermand JP, Brouet JC, Danon F, Seligmann M. Gamma heavy chain “disease”: heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medicine (Baltimore) 1989;68:321–35.CrossrefPubMedGoogle Scholar

  • 5.

    Kaleta E, Kyle R, Clark R, Katzmann J. Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays. Clin Chem Lab Med 2014;52(5):665–9.PubMedWeb of ScienceGoogle Scholar

  • 6.

    Gulli F, Napodano C, Pocino K, Cuccaro A, Hohaus S, Basile U. Heavy chain disease: our experience. Clin Chem Lab Med 2018;56:e10–2.Web of ScienceGoogle Scholar

  • 7.

    Johannis W, Blommer J, Klatt AR, Renno JH, Wielckens K. Gamma heavy chain disease in a patient with rheumatoid arthritis – a laboratory evaluation. Biochem Med (Zagreb) 2012;22:373–9.Google Scholar

About the article

Corresponding author: Christoph Robier, MD, PD, Institute of Laboratory Diagnostics, Hospital of the Brothers of St. John of God, Bergstr. 27, 8020 Graz, Austria, Phone: +43 316 5989 26671, Fax: +43 316 5989 21505


Received: 2017-10-03

Accepted: 2017-11-20

Published Online: 2018-01-09

Published in Print: 2018-05-24


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 56, Issue 6, Pages e154–e156, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2017-0891.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in